C12N 2502/1192
Lymphatic cells
C12N2502/1192 (Lymphatic cells) appears on 19 US grants and 24 published applications in this corpus.
Search patents in C12N- Granted patents
- 19
- Published applications
- 24
- Assignees
- 23
- Inventors
- 58
- Latest grant
- 11 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 3 | 3 |
| 2011 | 4 | 3 |
| 2012 | 4 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- COVID-19 peptide specific T-cells and methods of treating and preventing COVID-1911 Jan 2022US 11,219,684 B1Tevogen Bio Inc.
- COVID-19 peptide specific T-cells and methods of treating and preventing COVID-1928 Dec 2021US 11,207,401 B1Tevogen Bio Inc.
- COVID-19 peptide specific T-cells and methods of treating and preventing COVID-197 Dec 2021US 11,191,827 B1Tevogen Bio Inc.
- Artificial peritoneal tissue and method for producing same17 Nov 2020US 10,837,002 B2Hirosaki University
- Method for producing artificial skin model, and artificial skin model11 Sep 2018US 10,073,085 B2Osaka University
- Thymic epithelial cell production method30 Oct 2025US 2025/0332259 A1Kyoto University
- Devices and methods for simulating a function of liver tissue25 May 2023US 2023/0159899 A1Emulate, Inc.
- Rapid and efficient method for expanding human mesenchymal stem cells in vitro and application thereof24 Feb 2022US 2022/0056416 A1Affiliated Hospital of Zunyi Medical University
- Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity23 Dec 2021US 2021/0393681 A1Therapeutic Solutions International, Inc.
- Devices and methods for simulating a function of a liver tissue28 Mar 2019US 2019/0093077 A1Emulate, Inc.
Most cited
By later US patents
- Artificial immune system: methods for making and use32US 8,288,159 B2Sanofi Pasteur Vaxdesign Corp. et al. · 2012
- Methods for antibody production29US 8,298,823 B2Sanofi Pasteur Vaxdesign Corporation · 2012
- Artificial immune system: methods for making and use10US 7,855,074 B2Vaxdesign Corporation · 2010
- In vitro germinal centers4US 8,003,385 B2Sanofi Pasteur Vax Design Corp. · 2011
- Disease model incorporation into an artificial immune system (AIS)3US 7,771,999 B2Vaxdesign Corporation · 2010